Top Markets
#1 Cortex Cortex +32.82%
#2 龙虾 (Lobster) 龙虾 (Lobster) +32.56%
#3 Akedo Akedo +23.89%
#4 DexNet DexNet +23.19%
#5 Pons Pons +16.16%
#6 wojak wojak +15.73%
#7 OpenEden OpenEden +15.27%
#8 APEX APEX +13.92%
#9 The Black Bull The Black Bull +10.83%
#10 Official Trump Official Trump +9.80%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Bora Pharmaceuticals Co., Ltd. Bora Pharmaceuticals Co., Ltd.

Bora Pharmaceuticals Co., Ltd.

6472
Classifica tra le azioni #6988
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive... Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
Prezzo delle azioni
$13.85
Capitalizzazione di mercato
$1.76B
Variazione (1 giorno)
-0.91%
Variazione (1 anno)
-42.37%
Paese
TW
Scambia Bora Pharmaceuticals Co., Ltd. (6472)

Categoria

Healthcare
Ricavi di Bora Pharmaceuticals Co., Ltd. (6472)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Bora Pharmaceuticals Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Bora Pharmaceuticals Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN